WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) announced the
initiation of a Phase 2 clinical trial with the company's glucagon receptor
antagonist LGD-6972 for the treatment of type 2 diabetes mellitus. The
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) partner Retrophin,
Inc. (RTRX) reported positive top-line results from the Phase 2 DUET study of
sparsentan for the treatment of focal segmental glomerulosclerosis, a kidney
Analysts at CIBC upgraded Spectra Energy Corp. (NYSE: SE) from Sector Performer to Outperformer. Spectra Energy shares declined 1.10 percent to $40.55 in pre-market trading.
Deutsche Bank upgraded Ligand Pharmaceuticals Inc. ...
Shares of Mylan NV (NASDAQ: MYL) have tumbled 10 percent this week over concerns regarding its huge price increase for its Epipen product. The entire biotech sector crashed Wednesday, after Democratic Presidential nominee Hillary Clinton...
$108.97 - Intraday high
$108.07 - Tuesday close
$106.00 - Area of last three lows
$102.95 - Current price as of 3:25 PM
$101.69 - Intraday low as of 3:25 PM
$101.15 - March 29 low
$100.81 - March 28 low
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) hit a 52-week high of $139.79 at the beginning of August. Since then, the stock has been steadily declining and as of Wednesday was trading for less than $109 per share.
The stock is now nearly flat...
$139.79 - August 1 high (all-time-high)
$138.53 - August 1 close (all-time-closing high)
$113.47 - Monday close
$113.25 - Tuesday high
$111.31 - Intraday high as of 12:16 PM
$110.92 - Tuesday close
Shares of Ligand Pharmaceuticals Inc. (NASDAQ: LGND) have gained 6.1 percent over the year, posting a performance similar to that of the Dow Jones Industrial Average. Over the past six months, however, the stock moved up more than 30 percent. The...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Ligand Pharmaceuticals (LGND):